SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: biostruggle who wrote (1653)2/13/2002 4:58:14 PM
From: biostruggle  Respond to of 10345
 
Part of Moody's release

Moody's notes that Elan reported $594 million in cash flow from operations in 2001 on a U.S. GAAP basis. However, Moody's believes that after certain adjustments -- including interest on off-balance sheet debt, and any one-time benefits from 2001 product rationalization -- the company's ongoing rate of operating cash flow generation is substantially lower



To: biostruggle who wrote (1653)2/13/2002 4:59:34 PM
From: Qualified Opinion  Read Replies (2) | Respond to of 10345
 
A lot of speculation on Moody's part.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News